Human Papillomavirus Positivity in the Anal Canal in HIV-Infected and HIV-Uninfected Men Who Have Anal Sex with Men in Guangzhou, China: Implication for Anal Exams and Early Vaccination

Table 3

Detection of anal HPV among HIV-infected and HIV-uninfected men who have sex with men in Guangzhou.

(a) DNA positivity

	, %
	HIV-infected		HIV-uninfected		All
	()		()		()
Any type tested	64	81.0	41	48.2	105	64.0
High risk types
Any high risk types	40	50.6	23	27.1	63	38.4
HPV 16	17	21.5	12	14.1	29	17.7
HPV 18	8	10.1	2	2.4	10	6.1
HPV 26	2	2.5	1	1.2	3	1.8
HPV 31	2	2.5	0	0	2	1.2
HPV 33	7	8.9	2	2.4	9	5.5
HPV 35	1	1.3	1	1.2	2	1.2
HPV 39	3	3.8	0	0	3	1.8
HPV 45	1	1.3	1	1.2	2	1.2
HPV 51	2	2.5	2	2.4	4	2.4
HPV 52	8	10.1	3	3.5	11	6.7
HPV 53	2	2.5	3	3.5	5	3.1
HPV 56	2	2.5	0	0	2	1.2
HPV 58	6	7.6	2	2.4	8	4.9
HPV 59	5	5.1	2	2.4	6	3.7
HPV 66	2	2.5	2	2.4	4	2.4
HPV 68	5	6.3	3	3.5	8	4.9
HPV 73	0	0	1	1.2	1	0.6
HPV 82	1	1.3	2	2.4	3	1.8
Low risk types
Any low risk type	44	55.7	27	31.8	71	43.3
HPV 6	23	29.1	11	12.9	34	20.7
HPV 11	15	19.0	9	10.6	24	14.6
HPV 40	3	3.8	1	1.2	4	2.4
HPV 42	4	5.1	1	1.2	5	3.1
HPV 43	3	3.8	2	2.4	5	3.1
HPV 44	2	2.5	1	1.2	3	1.8
HPV 54	2	2.5	1	1.2	3	1.8
HPV 61	2	2.5	3	3.5	5	3.1
HPV 81	0	0	2	2.4	2	1.2
HPV 84	0	0	3	3.5	3	1.8
HPV 6/11	36	45.6	18	21.2	54	32.9
HPV 16/18	25	31.7	14	16.5	39	23.8
Any 4-valent vaccine type	51	64.6	28	32.9	79	48.2
HPV 16/18/31/33/45/52/58	35	44.3	19	22.4	54	32.9
Any 9-valent vaccine type	59	74.7	31	36.5	90	54.9

(b) Detection of multiple HPV types

	, %
	HIV-infected		HIV-uninfected		All
	()		()		()
Any type
Median, IQR	1, 0–5		0, 0–4		1, 0–6
0	15	19.0	44	51.8	59	36.0
1	40	50.6	27	31.8	67	40.9
2	8	10.1	7	8.2	15	9.2
3	6	7.6	3	3.5	9	5.5
4+	10	12.7	4	4.7	14	8.5
4-valent vaccine types
Median, IQR	1, 0–2		0, 0–2		0, 0–2
0	28	35.4	57	60.1	85	51.8
1	41	51.9	23	27.1	64	39.0
2	8	10.1	4	4.7	12	7.3
3	2	2.5	1	1.2	3	1.8
9-valent vaccine types
Median, IQR	1, 0–3		0, 0–2		1, 0–3
0	20	25.3	54	63.5	74	45.1
1	41	51.9	23	27.1	64	39.0
2	10	12.7	6	7.1	16	9.8
3	7	8.9	1	1.2	8	4.9
4+	1	1.3	1	1.2	2	1.2

Notes. . .